Optimizing Clinical Trial Applications: A Comprehensive Webinar
In an informative webinar, participants can delve into the nuances of optimally managing Investigational New Drug (IND) and Clinical Trial Application (CTA) submissions. This session emphasizes aligned chemistry, manufacturing, and controls (CMC) alongside regulatory strategies to ensure successful applications. Attendees will glean valuable knowledge regarding essential CMC requirements vital for early-phase development, and they will explore strategies designed to leverage accelerated CMC programs.
Key Learnings from Expert Speakers
During the event, esteemed speakers will provide key insights regarding the clinical trial authorization requirements from regulatory bodies such as the FDA and EMA. Attendees can expect to learn effective strategies to minimize regulatory gaps that may arise when transitions are made from US-based trials to those conducted in Europe. Additional topics include the vital support offered by the FDA and EMA regarding the importation requirements for investigational drugs into the EU.
Understanding Regulatory Requirements and Solutions
The wealth of knowledge shared by speakers will cover both CMC requirements and the regulatory landscape. Participants can look forward to discussions on FDA and EMA filing requirements and practical solutions to technical challenges faced during the early phases of drug substance and product development. The insights into transitioning from US to EU regulatory landscapes will arm attendees with actionable strategies.
Why Join the Webinar?
Understanding the intricacies of CMC strategies alongside a well-structured regulatory approach is essential for enhancing the success rates and efficiency of both IND and CTA submissions. Participants in the webinar will have the opportunity to learn from expert perspectives, which will focus on identifying and closing regulatory gaps, optimizing timelines, and streamlining the early phases of development.
Explore Real-World Solutions
Expert speakers will discuss real-world insights into overcoming CMC hurdles during the preparation of IND and CTA submissions. They will share approaches on aligning technical documentation with the evolving expectations of regulatory bodies, as well as valuable lessons learned from supporting global submissions across the US and Europe.
Registration Details
This interactive session will be led by William Lian, the Director of Filing and Regulatory Affairs at BioDuro, along with Arna Hrund Arnardóttir, PhD, a Senior Consultant at DADA Consultancy. Interested participants are encouraged to register for the live webinar scheduled for a future date at 10 AM EDT (4 PM CEST).
About the Hosting Organization
Xtalks, a leading provider of educational webinars and digital content in the life sciences and healthcare sectors, is committed to empowering professionals with access to high-quality educational resources. Every year, Xtalks serves thousands of industry professionals, including those from various fields such as pharmaceutical, biotechnology, and healthcare, offering them essential knowledge that helps them remain at the forefront of industry developments, regulations, and job opportunities.
Connect with Xtalks
To learn more about the vast array of resources available through Xtalks or for more information regarding hosting a webinar, interested parties can visit their official website.
Frequently Asked Questions
What is the focus of the upcoming webinar?
The webinar focuses on optimizing Investigational New Drug (IND) and Clinical Trial Application (CTA) submissions through aligned CMC and regulatory strategies.
Who are the speakers for the webinar?
The speakers include William Lian from BioDuro and Arna Hrund Arnardóttir from DADA Consultancy.
When will the webinar take place?
The specific date and time for the webinar will be announced soon.
How can I register for the webinar?
Registration information will be made available on the Xtalks website.
What is Xtalks' mission?
Xtalks aims to provide essential educational resources for professionals in the life sciences and healthcare sectors to keep them informed and equipped for industry challenges.
